Experiment 342228

Worktypes

ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SANDARACOPIMAR-7-15-DIENE,2-ALPHA-3-BETA-DIHYDROXY: 19-(1'-FORMYL)-GLYCOSIDESANDARACOPIMAR-7-15-DIENE,2-ALPHA-3-BETA-DIHYDROXY: 19-O-BETA-D-GLUCOSIDESANDARACOPIMAR-7-15-DIENE,3-BETA-HYDROXY: 19-O-BETA-D-GLUCURONIDESANDARACOPIMAR-7-15-DIENE,3-BETA-HYDROXY: 19-O-BETA-D-GLYCOSIDESANDARACOPIMAR-7-15-DIENE,2-ALPHA-3-BETA-DIHYDROXY: 19-O-BETA-D-GLUCURONIDESANDARACOPIMAR-7-15-DIENE,3-OXO: 19-O-BETA-D-GLUCOSIDESANDARACOPIMAR-7-15-DIENE,3-BETA-HYDROXY: 19-O-BETA-D-GLUCOSIDESANDARACOPIMAR-7-15-DIENE,3-BETA-HYDROXY: 19-(1'-FORMYL)-GLYCOSIDE

Details

PropertyValue
Pharmacology
ANTIFUNGAL ACTIVITY
OrganismOospora virescens (HYPHOMYCETES)
CitationCAGNOLI-BELLAVITA,N:. (1974). GLYCOSIDE METABOLITES OF OOSPORA VIRESCENS FUNGUS.. ()
Amount utilized
Compound isolated
Number2
Qualitative resultACTIVE
AnimalAGAR PLATE
Dose expressionDOSE